Pharmaceutical Giant Invests Over USD 220 Million to Expand Production in Singapore
AbbVie, a leading pharmaceutical company, has initiated a new USD 223 million expansion of its manufacturing facility in Singapore’s Tuas Biomedical Park. This investment aims to bolster AbbVie’s global manufacturing capacity for biologics, generating over...
European Wellness Group’s Expansion into Sabah
A European-based wellness center is targeting Sabah as a strategic location for its expansion into the ASEAN market, particularly in the wellness and biopharmaceutical sectors. Dr Mike Chan, Chairman of the European Wellness Biomedical Group based in Germany,...
Israel and Vietnam to Collaborate in 3D Printing for Healthcare
In January 2024, the 3D Technology in Medicine Center (3D Lab) of VinUniversity, a private university in Vietnam, signed a Memorandum of Understanding (MoU) with CustoMED – Sheba Medical Center, from Israel. This milestone marks a significant advancement in the...